[
  {
    "ts": null,
    "headline": "Invivyd, Inc. (IVVD) Reports Q2 Loss, Lags Revenue Estimates",
    "summary": "Invivyd, Inc. (IVVD) delivered earnings and revenue surprises of -200.00% and -23.96%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=8b5aa6bacce2501aa8d0a407417ab4082976f150fdf79f91babec5f236a125ca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755208801,
      "headline": "Invivyd, Inc. (IVVD) Reports Q2 Loss, Lags Revenue Estimates",
      "id": 136368237,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Invivyd, Inc. (IVVD) delivered earnings and revenue surprises of -200.00% and -23.96%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=8b5aa6bacce2501aa8d0a407417ab4082976f150fdf79f91babec5f236a125ca"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors",
    "summary": "In the closing of the recent trading day, Medtronic (MDT) stood at $91.98, denoting a -1% move from the preceding trading day.",
    "url": "https://finnhub.io/api/news?id=9f7a541dfc35fe2099c6081295a5e4e2382cb17d99d50e166423edc609f54472",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755207903,
      "headline": "Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors",
      "id": 136368238,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "In the closing of the recent trading day, Medtronic (MDT) stood at $91.98, denoting a -1% move from the preceding trading day.",
      "url": "https://finnhub.io/api/news?id=9f7a541dfc35fe2099c6081295a5e4e2382cb17d99d50e166423edc609f54472"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic announces cash dividend for second quarter of fiscal year 2026",
    "summary": "The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 14, 2025, approved the company's cash dividend for the second quarter of fiscal year 2026 of $0.71 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2025. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 48 consecutive years. The dividend is payable on October 17, 2025, t",
    "url": "https://finnhub.io/api/news?id=d91a574164435d93c10a8fe6acb1d7fb918a7982e7dadd1ab5f235ae160f1b30",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755202500,
      "headline": "Medtronic announces cash dividend for second quarter of fiscal year 2026",
      "id": 136368239,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 14, 2025, approved the company's cash dividend for the second quarter of fiscal year 2026 of $0.71 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2025. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 48 consecutive years. The dividend is payable on October 17, 2025, t",
      "url": "https://finnhub.io/api/news?id=d91a574164435d93c10a8fe6acb1d7fb918a7982e7dadd1ab5f235ae160f1b30"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic PLC stock underperforms Thursday when compared to competitors",
    "summary": "Medtronic PLC stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=1db2860222daf6e7bc734eebd150189b8170b7debfe9f24d22dc37cb2334093e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755189420,
      "headline": "Medtronic PLC stock underperforms Thursday when compared to competitors",
      "id": 136387936,
      "image": "",
      "related": "MDT",
      "source": "MarketWatch",
      "summary": "Medtronic PLC stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=1db2860222daf6e7bc734eebd150189b8170b7debfe9f24d22dc37cb2334093e"
    }
  },
  {
    "ts": null,
    "headline": "BNY Mellon Global Equity Income Fund Q2 2025 Commentary",
    "summary": "BNY Mellon Global Equity Income Fund underperformed its benchmark index, the FTSE World Index, during the second quarter of 2025. Read more here.",
    "url": "https://finnhub.io/api/news?id=d1967e0e887970a6d5dcdb58c9d9e463c15a594900795296dd6946634ca975b6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755187440,
      "headline": "BNY Mellon Global Equity Income Fund Q2 2025 Commentary",
      "id": 136351716,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/171573445/image_171573445.jpg?io=getty-c-w1536",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "BNY Mellon Global Equity Income Fund underperformed its benchmark index, the FTSE World Index, during the second quarter of 2025. Read more here.",
      "url": "https://finnhub.io/api/news?id=d1967e0e887970a6d5dcdb58c9d9e463c15a594900795296dd6946634ca975b6"
    }
  },
  {
    "ts": null,
    "headline": "FDA approved AI device that predicts cancer prognosis",
    "summary": "The ArteraAI prostate test uses artificial intelligence and biomarkers to predict if standard hormone therapy will be effective and for how long.",
    "url": "https://finnhub.io/api/news?id=8a1d3087a2a07b626010064cadc612315fefb2fe10ffc284864907bfd06c22b1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755187292,
      "headline": "FDA approved AI device that predicts cancer prognosis",
      "id": 136408327,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The ArteraAI prostate test uses artificial intelligence and biomarkers to predict if standard hormone therapy will be effective and for how long.",
      "url": "https://finnhub.io/api/news?id=8a1d3087a2a07b626010064cadc612315fefb2fe10ffc284864907bfd06c22b1"
    }
  },
  {
    "ts": null,
    "headline": "Smart Pills Company Evaluation Report 2025 | Medtronic, Olympus, and CapsoVision Lead with Minimally Invasive and AI-Enhanced Medical Technologies",
    "summary": "The 360 Quadrants analysis highlights the leaders in the global Smart Pills market, evaluating over 102 companies. Smart pills, also known as ingestible sensors or digital pills, offer revolutionary diagnostic functions and medication adherence monitoring by transmitting real-time data wirelessly. Key players include Medtronic, Olympus Corporation, and CapsoVision. The market's growth is driven by the demand for less invasive diagnostics and addressing medication non-adherence issues. Challenges",
    "url": "https://finnhub.io/api/news?id=40460e64d59f82e3905739ac37a78994dc3a07894eaa020864653d27b2a22993",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755181500,
      "headline": "Smart Pills Company Evaluation Report 2025 | Medtronic, Olympus, and CapsoVision Lead with Minimally Invasive and AI-Enhanced Medical Technologies",
      "id": 136349474,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The 360 Quadrants analysis highlights the leaders in the global Smart Pills market, evaluating over 102 companies. Smart pills, also known as ingestible sensors or digital pills, offer revolutionary diagnostic functions and medication adherence monitoring by transmitting real-time data wirelessly. Key players include Medtronic, Olympus Corporation, and CapsoVision. The market's growth is driven by the demand for less invasive diagnostics and addressing medication non-adherence issues. Challenges",
      "url": "https://finnhub.io/api/news?id=40460e64d59f82e3905739ac37a78994dc3a07894eaa020864653d27b2a22993"
    }
  },
  {
    "ts": null,
    "headline": "Insights Into Medtronic (MDT) Q1: Wall Street Projections for Key Metrics",
    "summary": "Beyond analysts' top-and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2025.",
    "url": "https://finnhub.io/api/news?id=22443a94d88c577a176649727da36a3baf80921f02ff7d0d5486f13ce2b837bf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755177302,
      "headline": "Insights Into Medtronic (MDT) Q1: Wall Street Projections for Key Metrics",
      "id": 136349475,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Beyond analysts' top-and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2025.",
      "url": "https://finnhub.io/api/news?id=22443a94d88c577a176649727da36a3baf80921f02ff7d0d5486f13ce2b837bf"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Taps Growing TMVR Market With Tendyne System",
    "summary": "ABT wins FDA nod for its Tendyne TMVR system, offering a minimally invasive option for patients with severe mitral valve disease.",
    "url": "https://finnhub.io/api/news?id=3e1ea26ddd9a0e687619ef40cce4ad2cf4a84338a6f8f76b579a9b568b37d8af",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755174780,
      "headline": "Abbott Taps Growing TMVR Market With Tendyne System",
      "id": 136349325,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "ABT wins FDA nod for its Tendyne TMVR system, offering a minimally invasive option for patients with severe mitral valve disease.",
      "url": "https://finnhub.io/api/news?id=3e1ea26ddd9a0e687619ef40cce4ad2cf4a84338a6f8f76b579a9b568b37d8af"
    }
  },
  {
    "ts": null,
    "headline": "BNY Mellon Dynamic Value Fund Q2 2025 Commentary",
    "summary": "BNY Mellon Dynamic Value Fund (Class A at NAV) returned 5.00% during the second quarter of 2025. Read more here.",
    "url": "https://finnhub.io/api/news?id=f892debf18bb28d5f4de92b2de0ead36e77ceb9bc730d5f77257082a710ef40e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755172800,
      "headline": "BNY Mellon Dynamic Value Fund Q2 2025 Commentary",
      "id": 136348578,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1344940351/image_1344940351.jpg?io=getty-c-w1536",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "BNY Mellon Dynamic Value Fund (Class A at NAV) returned 5.00% during the second quarter of 2025. Read more here.",
      "url": "https://finnhub.io/api/news?id=f892debf18bb28d5f4de92b2de0ead36e77ceb9bc730d5f77257082a710ef40e"
    }
  },
  {
    "ts": null,
    "headline": "3 Things You Need to Know if You Buy Medtronic Today",
    "summary": "Its stock has been languishing for a while, but management is working to get back on the growth track.",
    "url": "https://finnhub.io/api/news?id=7fb21680da4a0269c8378f0280103a8c8243f52564732b7513ba120efd2454da",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755165600,
      "headline": "3 Things You Need to Know if You Buy Medtronic Today",
      "id": 136344926,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Its stock has been languishing for a while, but management is working to get back on the growth track.",
      "url": "https://finnhub.io/api/news?id=7fb21680da4a0269c8378f0280103a8c8243f52564732b7513ba120efd2454da"
    }
  },
  {
    "ts": null,
    "headline": "Europe Neonatal Intensive Care Market Growth and Company Analysis Report 2025-2033 Featuring Masimo, 3M, Medtronic, Koninklijke Philips, Siemens, Terumo, AngioDynamics, Dragerwerk",
    "summary": "The Europe Neonatal Intensive Care Market is poised to grow from US$ 1.04 billion in 2024 to US$ 1.60 billion by 2033, boasting a CAGR of 4.96%. This growth is propelled by rising preterm birth rates, neonatal technology advancements, government regulations, and expanding hospital infrastructure, particularly in Eastern Europe. Key sectors include incubators, ventilators, and monitoring devices. Countries like Germany, France, and the UK are leading due to their robust NICU facilities and height",
    "url": "https://finnhub.io/api/news?id=f9456b23291a42f260325cde834ad7f8ff37b67cf6c8117f4bdf5ad455cbf840",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755158640,
      "headline": "Europe Neonatal Intensive Care Market Growth and Company Analysis Report 2025-2033 Featuring Masimo, 3M, Medtronic, Koninklijke Philips, Siemens, Terumo, AngioDynamics, Dragerwerk",
      "id": 136344927,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The Europe Neonatal Intensive Care Market is poised to grow from US$ 1.04 billion in 2024 to US$ 1.60 billion by 2033, boasting a CAGR of 4.96%. This growth is propelled by rising preterm birth rates, neonatal technology advancements, government regulations, and expanding hospital infrastructure, particularly in Eastern Europe. Key sectors include incubators, ventilators, and monitoring devices. Countries like Germany, France, and the UK are leading due to their robust NICU facilities and height",
      "url": "https://finnhub.io/api/news?id=f9456b23291a42f260325cde834ad7f8ff37b67cf6c8117f4bdf5ad455cbf840"
    }
  }
]